Geode Capital Management LLC grew its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 1.9% in the third quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 7,512,925 shares of the medical equipment provider's stock after acquiring an additional 143,440 shares during the period. Geode Capital Management LLC owned about 2.11% of Intuitive Surgical worth $3,677,194,000 at the end of the most recent reporting period.
Other large investors also recently modified their holdings of the company. State Street Corp increased its stake in shares of Intuitive Surgical by 1.4% in the third quarter. State Street Corp now owns 15,050,121 shares of the medical equipment provider's stock worth $7,393,673,000 after purchasing an additional 210,363 shares in the last quarter. FMR LLC grew its stake in Intuitive Surgical by 8.3% in the 3rd quarter. FMR LLC now owns 10,971,085 shares of the medical equipment provider's stock valued at $5,389,765,000 after buying an additional 838,793 shares in the last quarter. Fisher Asset Management LLC raised its holdings in Intuitive Surgical by 1.8% during the 3rd quarter. Fisher Asset Management LLC now owns 4,782,381 shares of the medical equipment provider's stock valued at $2,349,441,000 after acquiring an additional 86,208 shares during the period. Baillie Gifford & Co. lifted its position in shares of Intuitive Surgical by 0.6% during the third quarter. Baillie Gifford & Co. now owns 3,848,547 shares of the medical equipment provider's stock worth $1,890,676,000 after acquiring an additional 24,183 shares in the last quarter. Finally, Wellington Management Group LLP grew its position in shares of Intuitive Surgical by 1.7% in the third quarter. Wellington Management Group LLP now owns 3,115,024 shares of the medical equipment provider's stock valued at $1,530,318,000 after purchasing an additional 53,383 shares in the last quarter. Hedge funds and other institutional investors own 83.64% of the company's stock.
Insiders Place Their Bets
In other news, EVP Robert Desantis sold 376 shares of the business's stock in a transaction on Friday, November 29th. The shares were sold at an average price of $539.00, for a total transaction of $202,664.00. Following the sale, the executive vice president now owns 5,506 shares in the company, valued at approximately $2,967,734. The trade was a 6.39 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Amy L. Ladd sold 450 shares of Intuitive Surgical stock in a transaction dated Friday, September 13th. The shares were sold at an average price of $490.28, for a total transaction of $220,626.00. Following the transaction, the director now directly owns 821 shares of the company's stock, valued at approximately $402,519.88. This trade represents a 35.41 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 50,485 shares of company stock valued at $26,128,102 in the last quarter. Insiders own 0.90% of the company's stock.
Analysts Set New Price Targets
Several research analysts have commented on ISRG shares. Oppenheimer restated a "market perform" rating on shares of Intuitive Surgical in a research note on Friday, October 18th. Raymond James boosted their price objective on shares of Intuitive Surgical from $500.00 to $540.00 and gave the company an "outperform" rating in a research note on Monday, October 14th. Citigroup raised their price target on shares of Intuitive Surgical from $512.00 to $560.00 and gave the company a "buy" rating in a report on Thursday, August 22nd. JPMorgan Chase & Co. upped their price target on shares of Intuitive Surgical from $495.00 to $575.00 and gave the stock an "overweight" rating in a report on Friday, October 11th. Finally, Stifel Nicolaus lifted their price objective on Intuitive Surgical from $525.00 to $610.00 and gave the company a "buy" rating in a research note on Thursday, December 5th. One research analyst has rated the stock with a sell rating, four have given a hold rating and fifteen have given a buy rating to the company's stock. According to MarketBeat.com, Intuitive Surgical has a consensus rating of "Moderate Buy" and a consensus price target of $541.33.
View Our Latest Research Report on ISRG
Intuitive Surgical Stock Down 0.1 %
Shares of NASDAQ ISRG traded down $0.77 during midday trading on Tuesday, reaching $538.09. The company had a trading volume of 1,037,397 shares, compared to its average volume of 1,443,830. The stock has a market cap of $191.66 billion, a PE ratio of 86.51, a price-to-earnings-growth ratio of 5.41 and a beta of 1.38. Intuitive Surgical, Inc. has a one year low of $309.80 and a one year high of $556.23. The firm's fifty day moving average price is $517.16 and its 200-day moving average price is $475.65.
Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its quarterly earnings data on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share for the quarter, beating analysts' consensus estimates of $1.24 by $0.32. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. The firm had revenue of $2.04 billion during the quarter, compared to analyst estimates of $2.01 billion. As a group, equities research analysts expect that Intuitive Surgical, Inc. will post 5.45 EPS for the current year.
About Intuitive Surgical
(
Free Report)
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Read More
Before you consider Intuitive Surgical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Intuitive Surgical wasn't on the list.
While Intuitive Surgical currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.